Drug class
Synthetic glucocorticoid; inhaled and intranasal corticosteroid anti-inflammatory agent
Mechanism of action
Activates intracellular glucocorticoid receptors and regulates transcription of inflammatory mediators, reducing airway and nasal mucosal inflammation, oedema and mucus production.
General use cases
- Maintenance treatment of asthma with inhaled formulations; not for relief of acute bronchospasm
- Treatment of nasal symptoms associated with seasonal or perennial allergic rhinitis with authorised intranasal formulations
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
